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ABSTRACT
Objectives To examine the “Scottish effect”—namely, the
growing divergence between mortality in Scotland and
England that is not explained by national differences in
levels of deprivation—and, more specifically, to examine
the extent to which the Scottish effect is explained by
cross national differences in the prevalence of problem
drug use.
Design Secondary analysis of cohort study (the DORIS
study).
Participants 1033 Scottish drug users recruited to the
cohort study in 33 drug treatment facilities across
Scotland in 2001-2 and followed up 33 months later in
2004-5.
Results 38 deaths occurred in the cohort, giving a
standardised mortality ratio for the cohort of 1244 (95%
credibleinterval876to1678).Only22ofthe38deathsin
drug users were classified as drug related deaths. From
estimates of the size of the problem drug using
populations in both England and Scotland, the
contribution of deaths in drug users to national death
rates can be estimated: the attributable risk fraction for
Scotlandis17.3%(12.3%to22.8%)andthatforEngland
is 11.1% (7.8% to 14.8%). Excluding estimated numbers
of deaths in drug users would bring down age
standardised mortality at ages 15-54 years from 196 to
162 per 100000 in Scotland and from 138 to 122 per
100000 in England; 32.0% (22.3% to 43.0%) of the
excess mortality in Scotland is due to drug use.
ConclusionAlthoughproblemdruguseisalowprevalence
riskbehaviour,itcarriesahighmortality;thestandardised
mortality ratio for Scottish drug users is 12 times as high
as for the general population. The higher prevalence of
problemdruguseinScotlandthaninEnglandaccountsfor
a third of Scotland’s excess mortality over England.
Successful public health efforts to reduce the prevalence
ofproblemdruguseinScotlandordeathsinScottishdrug
userswouldhaveadramaticimpactonoverallmortalityin
Scotland.
INTRODUCTION
Death ratesare known tobe higherin Scotlandthanin
England and Wales. In recent years, although Scottish
death rates have been falling, the relative difference
between the nations has increased: mortality was 12%
higher in Scotland than in England and Wales in 1981
but 15% higher in 2001.
1 In the past, poorer health in
Scotland has been attributed to higher levels of
deprivation: if local mortality was adjusted for local
Carstairs deprivation scores (based on levels of adult
male employment, car ownership, social class compo-
sition, and overcrowding), 60% of Scotland’s excess
mortality in 1981 was explained by greater relative
deprivation.
2 However, by the 1991 census (and
continuing at the 2001 census) deprivation was
accounting for less than half of Scotland’s excess
mortality,
13 and the unaccounted for excess was
increasingly marked among the Scottish male popula-
tion aged 0-44 years.
1 This growing disproportionality
has been dubbed the “Scottish effect.”
Possible explanations for the Scottish effect reflect
thewiderdebatesthathavetakenplaceonthecausesof
inequalitiesinhealthintheUnitedKingdomeversince
the publication of the Black report in 1980.
4 Thus,
peoplehavesuggestedthatthe effectisa measurement
artefact, that Carstairs deprivation scores capture
relative deprivation less effectively in the 21st century
thantheydidin1981.Hanlonandcolleaguesdiscount
the artefact explanation and, pointing to higher levels
of alcohol consumption, lower levels of physical
activity, and a higher prevalence of smoking in
Scotland(comparedwithEngland),tentativelysuggest
that “Scots in an equivalent deprivation category have
higher levels of personal risk factors.”
1 Our purpose
hereistoendorsethatsuggestionandpositthatasingle
riskfactor—problemdruguse—mayberesponsiblefor
alargepartoftheobserved,deprivationadjusted,cross
national differences in rates of premature death.
METHODS
Numbers and trends in “drug related deaths” in
Scotland are regularly reported,
5 but the definition of
drugrelateddeathsusedinthesereportsisdeliberately
andproperlyarestrictiveone,limitedtodeathsdirectly
due to the pharmacological effect of an illicit drug.
6 In
ordertoestimatethenumbersofdeathsinapopulation
of drug users, deaths that embrace not just overdoses
from illicit drugs but also deaths from bloodborne
1Centre for Drug Misuse Research,
University of Glasgow, Glasgow
G11 6PW
2Vital Events Branch, General
Register Office for Scotland,
Edinburgh EH12 7TF
3MRC Social and Public Health
Sciences Unit, Glasgow G12 8RZ
Correspondence to: M Bloor
M.Bloor@socsci.gla.ac.uk
Cite this as: BMJ 2008;337:a478
doi:10.1136/bmj.a478
BMJ | ONLINE FIRST | bmj.com page 1 of 5infections, from violent assaults, from suicides, and
from other events associated with drug use, cohort
studies on populations of drug users are needed.
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DORIS (drug outcomes research in Scotland) is the
largest ever repeat interview study of Scottish drug
users,involvingfollowingup1033problemdrugusers
who started a new treatment episode in 33 drug
treatment agencies (representing a range of treatment
modalities and including treatment in prisons) across
Scotland in 2001-2. Of the 1180 problem drug users
who were asked to participate, 147 people refused,
givinga participationrate of87.5%;the mostcommon
reason given for refusal was lack of time. The DORIS
sample comprises one in 11 of the drug users entering
treatment in 2001 and returned in the Scottish drug
misuse database (a database of all new entrants into
drug treatment facilities), and the sociodemographic
profile of the sample is comparable to the profile of
returns made to that database in 2001.
9 DORIS
respondents had a mean age of 28, and 69% of
respondents were male; although misuse of several
drugs was the common pattern, the great majority of
respondents reported that their main drug was heroin.
We matched data between General Register Office
for Scotland (GROS) mortality data and those mem-
bersoftheDORISsamplewhowerelosttofollow-upat
33 months. The Vital Events Branch of GROS then
established which of the deaths in the DORIS cohort
hadpreviouslybeenclassifiedasadrugrelateddeathin
earlierannualreports.
5Wealsomadeinquirieswiththe
OfficeforNationalStatisticsinEnglandaboutwhether
thedeathofaDORISsamplememberwhohaddiedin
Englandhadbeenincludedintheirequivalentcountof
drug related deaths.
Estimates can be made of the totalnumber of deaths
in drug users (as opposed to drug related deaths) by
combining the standardised mortality ratio from the
DORIS cohort with prevalence data on problem drug
use (available for both Scotland and England),
1011
calculated by using population estimation methods.
These methods (identical for both the Scottish and the
English prevalence estimates) model the “hidden
population” of problem drug users not in contact
with services from overlaps between populations of
drug users known to a range of different services,
including the drug treatment services where the
DORIS sample was recruited. Therefore, any possible
numerator-denominatorbiasshouldbequitelimitedin
extent and estimates of death will include deaths of
hidden drug users as well as of those in contact with
services. The contribution of deaths among drug users
to overall Scottish and English death rates can be
calculated as the attributable risk fraction (ARF) in the
formula ARF=Ppdu(SMR/100−1)/(Ppdu(SMR/100−1)
+1), where Ppdu is the proportion of the population
who are problem drug users and SMR is the
standardised mortality ratio for that same subpopula-
tion calculated through indirect standardisation to the
Scottish population.
12
Detailed age and sex breakdowns are not publicly
available for the English problem drug user cohort
study that is the equivalent of DORIS (the national
treatment outcomes research study, NTORS), so we
have used the standardised mortality ratios for the
DORIS cohort to calculate both the English and the
Scottish attributable risk fractions. This seems to be
acceptable, as the overall DORIS and NTORS death
rates are nearly identical and the NTORS data were
gathered at an earlier period (1995-9) than DORIS
(2001-4). We calculated standardised mortality rates
for England and Scotland by direct standardisation to
the European standard population. We estimated the
standardised mortality for the non-drug using popula-
tion in the two countries and, comparing these rates
withtheobservedrates,estimatedtheproportionofthe
excess mortality in Scotland that was attributable to
drug use. Mortality data and population data came
from the Office for National Statistics and the General
Register Office (Scotland).
13-15
We report posterior means and 95% credible inter-
valsestimatedwithWinBUGS,
16basedontwoparallel
chains of length 10000 following a burn-in of 10000.
Thecredibleintervalsarerangesofvalueswithinwhich
therelevantparameterlieswithaprobabilityof0.95;in
thissense,theymaybeinterpretedinasimilarmanner
to confidence intervals. The relevant WinBUGS code
can be found on Leyland’s website (www.sphsu.mrc.
ac.uk/research_project.php?prjid=BUGSCODE&b
crumbs=MH.METH).
RESULTS
Deaths in DORIS cohort
Thirty eight deaths occurred in the 1033 DORIS
samplemembersinthe33monthperiod,ofwhichonly
just over half (22) were classified by the General
Register Office for Scotland/Office for National
Statistics as “drug related deaths.” The cause of death
of one cohort member remained unascertained,
despite further inquiries by the General Register
Office. Of the remaining 15 cohort deaths that were
notclassedasdrugrelated,sixweresuicides,including
three overdoses (of paracetamol, amitriptyline, and
colchicine), one was an overdose of “undetermined
intent” involving fluoxetine and propranolol, three
Table 1 |CrudedeathratesinDORISsample
Person
years
All
deaths
Drug related
deaths cohort
Crude death rate (95% CI)
per 1000 person years
Crude death rate (95% CI)
for drug related deaths cohort
Men 1953 27 15 14 (9 to 20) 7 (4 to 13)
Women 864 11 7 13 (6 to 23) 8 (3 to 17)
Total 2817 38 22 13 (10 to 18) 8 (5 to 12)
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(with a fourth due to endocarditis), two were due to
assaults, one was due to “alcoholic liver disease,” and
one was due to hypothermia/exposure.
ThemortalityintheDORISsampleiscomparableto
rates in other cohort studies of drug users in England
(the NTORS cohort) and abroad.
78 Table 1 shows
mortality as a crude death rate per 1000 person years,
where person years are calculated as the difference
between the dates of death and of the initial DORIS
interview.
Possible contribution of drug use to Scottish excess
mortality
ThestandardisedmortalityratioformenintheDORIS
cohort(whoseageatrecruitmentrangedfrom16to53,
with a mean age of 28) was 834 (95% credible interval
549 to 1182) (table 2). In 2002 the age standardised
mortality for Scottish men aged 15-54 was 259 per
100000, and for England it was 173 per 100000. For
the same age group, the prevalence of problem drug
use in Scotland in 2003 was 2.69% (95% confidence
interval 2.11% to 4.17%).
10 In England in 2004-5 the
prevalenceofproblemdruguseamongmenaged15to
64 was 1.32%.
11 Assuming that opiate use among men
aged 55 to 64 was negligible, this equates to a
prevalence of 1.65% among men aged 15 to 54.
Thesedataledtoanestimatedattributableriskfraction
of all deaths among male drug users in Scotland of
16.3% (95% credible interval 8.8% to 25.5%) and an
attributable risk fraction in England of 10.7% (6.8% to
15.1%).If the estimated deaths in drugusers in the two
male populations was excluded, the standardised
mortality in the two populations would fall from 259
per 100000 to 217 (95% credible interval 192 to 238)
per 100000 in Scotland and from 173 per 100000 to
154 (146 to 161) per 100000 for England. This
indicates that 27.5% (95% credible interval 9.3% to
50.3%)oftheexcessmortalityforScottishmenaged15
to 54 is due to the greater prevalence of problem drug
use in Scotland.
The overall (in men and women) standardised
mortality ratio for the DORIS cohort is 1244 (95%
credible interval 876 to 1678), and the overall
attributable risk fraction is 17.3% (12.3% to 22.8%)
for Scotland and 11.1% (7.8% to 14.8%) for England.
The corresponding prevalences of problem drug use
are1.84%(95%confidenceinterval1.84%to2.01%)for
Scotland and 1.07% (1.06% to 1.11%) for England.
Exclusionoftheestimateddeathsindrugusersresulted
in falls in the standardised mortality from 196 per
100000 to 162 (95% credible interval 150 to 173) per
100000 in Scotland and from 138 per 100000 to 122
(117to127)per100000 inEngland.Thissuggeststhat
32.0% (95% credible interval 22.3% to 43.0%) of the
excess Scottish mortality is due to the greater
prevalence of problem drug use in Scotland.
DISCUSSION
Our data suggest that one particular risk behaviour,
problem drug use, accounts for a third of excess
mortality in Scotland compared with England among
people aged 15 to 54, supporting Hanlon and
colleagues’ suggestion that the “Scottish effect” can
be explained by higher prevalences of risk behaviours
inScotlandthaninEnglandwithina particularlevel of
deprivation.Notealsothatarapidincreaseinproblem
drug use (and particularly heroin use) occurred in the
1980s in Scotland,
17 at the very point at which
deprivation measures (Carstairs deprivation scores)
began to accountfor lessthan halfof the cross national
variance in rates.
Uncertainties and limitations
Uncertainty intervals are attached to these various
estimates. For Scottish men aged 15-54 (for whom the
“Scottisheffect”isstrongest),deathsindruguserscould
beaccountingforasmuchashalforaslittleasatenthof
the excess Scottish mortality; however, intervals are
Table 2 |Proportionofproblemdrugusers,standardisedmortalityratios,attributableriskfractions,agestandardisedmortality,
excessmortality,andproportionofexcessduetodruguse(with95%credibleintervalsunlessstatedotherwise)inEnglandand
Scotland,formenandformenandwomencombined
Men Men and women
England Scotland England Scotland
Proportion (%) of problem drug users
(95% confidence interval)
1.65* 2.69 (2.11 to 4.17) 1.07 (1.06 to 1.11) 1.84 (1.84 to 2.01)
Standardisedmortalityratioinpopulation
of drug users (DORIS cohort)
† 834 (549 to 1182) † 1244 (876 to 1678)
Attributable risk fraction (%) 10.7 (6.8 to 15.1) 16.3 (8.8 to 25.5) 11.1 (7.8 to 14.8) 17.3 (12.3 to 22.8)
Age standardised mortality per 100 000 173 (170 to 175) 259 (250 to 267) 138 (136 to 139) 196 (191 to 201)
Excess mortality per 100 000 – 86 (77 to 95) – 58 (53 to 64)
Age standardised mortality per 100 000,
excluding deaths in drug users
154 (146 to 161) 217 (192 to 238) 122 (117 to 127) 162 (150 to 173)
Excess mortality per 100 000, excluding
deaths in drug users
– 63 (42 to 80) – 40 (32 to 47)
Proportionofexcessmortalityduetodrug
use (%)
– 27.5 (9.3 to 50.3) – 32.0 (22.3 to 43.0)
*95% confidence interval not given.
†Assumed to be same as for DORIS cohort.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 5narrower when deaths in men and women are
combined. The time periods of the different datasets
used are not wholly matched; although we have been
able to use datasets from contiguous time periods,
readersmustdecide onthe windows ofapplicability of
the different datasets.
The definitions of drug users used in the DORIS
study and the two different prevalence estimates differ
slightly: eligibility in the DORIS study was simply a
matter of starting a new episode of drug treatment; in
theEnglishprevalencestudytheestimaterelatedtouse
of opiates, crack/cocaine, or both; in the Scottish
prevalence study the estimate related to use of opiates,
benzodiazepines, or both. Such differences in defini-
tion raise the possibility of numerator-denominator
biases in mortality calculations, but the practical
importance of definitional differences in this instance
is small—for example, although the DORIS sample
might have started treatment because of misuse of a
range of different substances other than opiates or
benzodiazepines, in fact 88% of the sample had used
heroin in the three months before recruitment.
The formula used to calculate the attributable risk
fraction has been judged to be suitable when no
confounding of the exposure-disease association
exists,
18 but we cannot explore the possibility of such
confounding in these data. The mortality in DORIS is
consistent with that found in studies elsewhere,
712and
the DORIS sample is the largest repeat interview
cohortstudyofScottishdrugusers.Thus,althoughthe
samplerepresentslessthanatenthoftheannualtotalof
people seeking treatment for drug use in Scotland, our
claim that mortality in the DORIS sample indicates
that deaths in drug users represent an important
fraction of deaths in the Scottish 15-54 year old
population is warranted. However, a larger follow-up
study of drug users would provide more certain
estimates of mortality in drug users.
Implications
Problem drug use is a low prevalence risk behaviour
compared with tobacco consumption, high alcohol
consumption, and low levels of physical activity, but it
carries a high mortality: mortality in the DORIS
sample was 12 times that of the general Scottish
population aged 15 to 54. This high mortality is not
fully reflected in published reports on “drug related
deaths,”asdefinitionofsuchdeathsisdeliberatelyand
properly a restrictive one, limited to overdoses from
illicit drugs and not the wider spectrum of deaths
(including deaths from infections, assaults, and over-
dose from drugs such as paracetamol) found in the
DORIS sample. In the DORIS sample, only just over
half the deaths that occurred among drug users were
classed as drug related deaths. It follows that deaths in
problem drug users are a potentially important
contributor to national and local mortality.
1920
Explorations of health inequalities, reflected in
differential mortality, thus need to embrace studies of
differencesintheprevalenceofproblemdruguse.The
identificationofanimportantroleforproblemdruguse
in understanding excess mortality does not, of course,
decrease the importance of the link between socio-
economic deprivation and poor health, as the associa-
tionbetweenrelativedeprivationanduptakeofdrugsis
long established.
62122
Successful public health initiatives to reduce the
prevalence of problem drug use or to reduce deaths
among drug users would have a strong impact on
overallmortalityinbothScotlandandEngland.Policy
efforts to reduce health inequalities could and should
makedrugmisuseaprimetarget,andtheneedtotackle
drug misuse as part of a strategy to reduce health
inequalities was recognised in the report of the
Ministerial Task Force on Health Inequalities pub-
lishedon19Junethisyear
23.Theevidenceismixedon
how successful current public health initiatives have
been in Scotland. No trend data on deaths in Scottish
drugusersareavailable,butthatfractionofsuchdeaths
thatare classedasdrugrelateddeathshascontinuedto
rise.
24 However, the latest Scottish prevalence esti-
mates show a small fall in the prevalence of problem
drug use between 2000 and 2003.
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